Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Imago Raises $80m Series C To Take Bomedemstat Into Phase III
Company Plans IPO In 2021 To Fund Additional Pivotal Trials
Nov 19 2020
•
By
Mandy Jackson
Imago closed an $80m series C with plans to launch an IPO in 2021 • Source: Shutterstock
More from Financing
More from Business